EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The Genetic Landscape of Hereditary Spastic Paraplegia in Greece

Georgios Koutsis iD, Viorica Chelban, Chrisoula Kartanou, Zoi Kontogeorgiou, Chrysoula Koniari, Nikolaos Ragazos, Charalampos Voudommatis, Kristina Zhelcheska, David S Lynch, Reza Maroofian, Ehsan Barkhordari, Rahema Mohammad und 8 weitere

Clinical Genetics · 2026-05 · 109 (5) · 837-846

DOI: 10.1111/cge.70113 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Genetics, online erschienen am 24.11.2025. Verfasst von Georgios Koutsis und 19 weiteren Autor:innen. Beteiligte Einrichtung: Neurogenetics Unit, 1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece. Hauptthemen laut MEDLINE: Spastic Paraplegia, Hereditary, Genetic Predisposition to Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Genesis Pharma, Association of British Neurologists' Academic Clinical Training Research Fellowship, Guarantors of Brain.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hereditary spastic paraplegia (HSP) is a neurogenetic disorder characterized by progressive, length‐dependent degeneration of the upper motor neurons. We investigated 112 Greek HSP index cases collected over more than 25 years from all regions of the country, using a combination of next generation sequencing and multiplex ligation‐dependent probe amplification. In total, we identified a causative variant in 68 patients, corresponding to a diagnostic yield of 60.7%. The diagnostic yield was 62.8% in autosomal dominant HSP, 77.8% in autosomal recessive HSP and 50.0% in sporadic cases. We identified 7 novel causative variants in SPAST , SPG7 , and CYP7B1 . We found causative variants in a total of 18 different genes. The most commonly involved genes, affecting more than one family, were SPAST (25.0%), SPG11 (12.5%), CYP7B1 (3.6%), SPG7 (3.6%), KIF5A (2.7%), ABCD1 (1.8%) and PSEN1 (1.8%). Variants in ATL1 , REEP1 , BSCL2 , PLP1 , WASCHC5 , AP5Z1 , CYP27A1 , SOD1 , POLR3A, GFAP and ARG1 were identified in single families. This study presents a comprehensive overview of the phenotypic and genotypic spectrum of HSP in the Greek population, expanding previous data, and contributing to the characterisation of further pathogenic variants linked to HSP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spastic Paraplegia, HereditaryGenetic Predisposition to DiseaseHumansGreeceMaleFemaleCytochrome P450 Family 7AdultMiddle AgedSpastinMutationAdolescentHigh-Throughput Nucleotide SequencingChildSteroid HydroxylasesYoung AdultAgedPedigreeChild, PreschoolGenetic Association StudiesATPases Associated with Diverse Cellular ActivitiesMetalloendopeptidases

Stichwörter der Autor:innen

MLPAGreeceGreek populationhereditary spastic paraplegianext generation sequencingwhole‐exome‐sequencing

Substanzen

Cytochrome P450 Family 7CYP7B1 protein, humanSpastinSPAST protein, humanSteroid HydroxylasesSPG7 protein, humanSPG11 protein, humanATPases Associated with Diverse Cellular ActivitiesMetalloendopeptidasesProteins

Autor:innen und Institutionen

  • Neurogenetics Unit, 1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.
  • Neurobiology and Medical Genetics Laboratory, "Nicolae Testemitanu" State University of Medicine and Pharmacy, Chisinau, Republic of Moldova.
  • NIHR University College London Hospitals Biomedical Research Centre, London, UK.
  • Department of Neurology, School of Health Sciences, Faculty of Medicine, University of Crete, Crete, Greece.
  • Department of Neurology, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.

ORCID-Profile: Georgios Koutsis, Henry Houlden

Förderung

  • Genesis Pharma
  • Association of British Neurologists' Academic Clinical Training Research Fellowship
  • Guarantors of Brain
  • MSA Trust
  • MSA Coalition
  • MANX MSA
  • King Baudouin Foundation
  • National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre

Zitieren

APA

Koutsis, G., Chelban, V., Kartanou, C., Kontogeorgiou, Z., Koniari, C., Ragazos, N., Voudommatis, C., Zhelcheska, K., Lynch, D. S., Maroofian, R., Barkhordari, E., Mohammad, R., Zaganas, I., Drakos, M., Xiromerisiou, G., Dardiotis, E., Stefanis, L., Panas, M., Houlden, H., & Karadima, G. (2026). The Genetic Landscape of Hereditary Spastic Paraplegia in Greece. Clinical Genetics, 109(5), 837-846. https://doi.org/10.1111/cge.70113

Vancouver

Koutsis G, Chelban V, Kartanou C, Kontogeorgiou Z, Koniari C, Ragazos N, et al. The Genetic Landscape of Hereditary Spastic Paraplegia in Greece. Clinical Genetics. 2026;109(5):837-846. doi:10.1111/cge.70113

BibTeX
@article{Koutsis2026,
  author = {Koutsis, Georgios and Chelban, Viorica and Kartanou, Chrisoula and Kontogeorgiou, Zoi and Koniari, Chrysoula and Ragazos, Nikolaos and Voudommatis, Charalampos and Zhelcheska, Kristina and Lynch, David S and Maroofian, Reza and Barkhordari, Ehsan and Mohammad, Rahema and Zaganas, Ioannis and Drakos, Minas and Xiromerisiou, Georgia and Dardiotis, Efthymios and Stefanis, Leonidas and Panas, Marios and Houlden, Henry and Karadima, Georgia},
  title = {The Genetic Landscape of Hereditary Spastic Paraplegia in Greece},
  journal = {Clinical Genetics},
  year = {2026},
  volume = {109},
  number = {5},
  pages = {837--846},
  doi = {10.1111/cge.70113}
}
Kostenlos starten →